TNBC, accounting for about 15% to 20% of all cases of invasive breast cancer, is distinguished by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) expression on the tumor cell membrane[6]. This evidence concerns the gene ERBB2 and invasive breast carcinoma.